{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:22:06Z","timestamp":1792516926493,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,2,8]],"date-time":"2017-02-08T00:00:00Z","timestamp":1486512000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,2,8]],"date-time":"2017-02-08T00:00:00Z","timestamp":1486512000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Early assessment of necrotising soft tissue infection (NSTI) is challenging. Analysis of inflammatory markers could provide important information about disease severity and guide decision making. For this purpose, we investigated the association between cytokine levels and the Laboratory Risk Indicator for Necrotising Fasciitis (LRINEC)-score, disease severity and mortality in NSTI patients. In 159 patients, plasma was analysed for IL-1\u03b2, IL-6, IL-10 and TNF-\u03b1 upon admission. The severity of NSTI was assessed by SAPS, SOFA score, septic shock, microbial aetiology, renal replacement therapy and amputation. We found no significant difference in cytokine levels according to a LRINEC- score above or below 6 (IL-1\u03b2: 3.0 vs. 1.3; IL-6: 607 vs. 289; IL-10: 38.4 vs. 38.8; TNF-\u03b1: 15.1 vs. 7.8\u2009pg\/mL, <jats:italic>P<\/jats:italic>\u2009&gt;\u20090.05). Patients with \u03b2-haemolytic streptococcal infection had higher level of particularly IL-6. There was no difference in mortality between patients with a LRINEC-score above or below 6. In the adjusted analysis assessing 30-day mortality, the association was strongest for IL-1\u03b2 (OR 3.86 [95% CI, 1.43-10.40], <jats:italic>P<\/jats:italic>\u2009=\u20090.008) and IL-10 (4.80 [1.67-13.78], <jats:italic>P<\/jats:italic>\u2009=\u20090.004). In conclusion, we found no significant association between the LRINEC-score and cytokine levels on admission. IL-6 was consistently associated with disease severity, whereas IL-1\u03b2 had the strongest association with 30-day mortality.<\/jats:p>","DOI":"10.1038\/srep42179","type":"journal-article","created":{"date-parts":[[2017,2,8]],"date-time":"2017-02-08T11:58:55Z","timestamp":1486555135000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Association between cytokine response, the LRINEC score and outcome in patients with necrotising soft tissue infection: a multicentre, prospective study"],"prefix":"10.1038","volume":"7","author":[{"given":"Marco Bo","family":"Hansen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars Simon","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattias","family":"Svensson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavya","family":"Chakrakodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trond","family":"Bruun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin Bruun","family":"Madsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Perner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Garred","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole","family":"Hyldegaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Norrby-Teglund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"INFECT study group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Nekludov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Arnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Ros\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicklas","family":"Oscarsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ylva","family":"Karlsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oddvar","family":"Oppegaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steinar","family":"Skrede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Itzek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Mygind","family":"Wahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten","family":"Hedetoft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina Falcon","family":"B\u00e6rnthsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasmus","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torbj\u00f8rn","family":"Nedreb\u00f8","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,8]]},"reference":[{"key":"BFsrep42179_CR1","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.jinf.2011.07.019","volume":"63","author":"DK Das","year":"2011","unstructured":"Das, D. K., Baker, M. G. & Venugopal, K. Increasing incidence of necrotizing fasciitis in New Zealand: a nationwide study over the period 1990 to 2006. J. Infect. 63, 429\u2013433 (2011).","journal-title":"J. Infect."},{"key":"BFsrep42179_CR2","first-page":"618067","volume":"2015","author":"L Oud","year":"2015","unstructured":"Oud, L. & Watkins, P. Contemporary trends of the epidemiology, clinical characteristics, and resource utilization of necrotizing fasciitis in Texas: a population-based cohort study. Crit Care Res Pract 2015, 618067 (2015).","journal-title":"Crit Care Res Pract"},{"key":"BFsrep42179_CR3","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1128\/JCM.01626-07","volume":"46","author":"B Luca-Harari","year":"2008","unstructured":"Luca-Harari, B. et al. Clinical and epidemiological aspects of invasive Streptococcus pyogenes infections in Denmark during 2003 and 2004. J. Clin. Microbiol. 46, 79\u201386 (2008).","journal-title":"J. Clin. Microbiol."},{"key":"BFsrep42179_CR4","doi-asserted-by":"publisher","first-page":"E545","DOI":"10.1111\/1469-0691.12276","volume":"19","author":"T Bruun","year":"2013","unstructured":"Bruun, T. et al. Necrotizing soft tissue infections caused by Streptococcus pyogenes and Streptococcus dysgalactiae subsp. equisimilis of groups C and G in western Norway. Clin. Microbiol. Infect. 19, E545\u2013550 (2013).","journal-title":"Clin. Microbiol. Infect."},{"key":"BFsrep42179_CR5","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1086\/511638","volume":"44","author":"DA Anaya","year":"2007","unstructured":"Anaya, D. A. & Dellinger, E. P. Necrotizing soft-tissue infection: diagnosis and management. Clin. Infect. Dis. 44, 705\u2013710 (2007).","journal-title":"Clin. Infect. Dis."},{"key":"BFsrep42179_CR6","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1086\/653116","volume":"51","author":"L Johansson","year":"2010","unstructured":"Johansson, L., Thulin, P., Low, D. E. & Norrby-Teglund, A. Getting under the skin: the immunopathogenesis of Streptococcus pyogenes deep tissue infections. Clin. Infect. Dis. 51, 58\u201365 (2010).","journal-title":"Clin. Infect. Dis."},{"key":"BFsrep42179_CR7","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.jhin.2010.01.028","volume":"75","author":"MS Morgan","year":"2010","unstructured":"Morgan, M. S. Diagnosis and management of necrotising fasciitis: a multiparametric approach. J. Hosp. Infect. 75, 249\u2013257 (2010).","journal-title":"J. Hosp. Infect."},{"key":"BFsrep42179_CR8","doi-asserted-by":"publisher","first-page":"R15","DOI":"10.1186\/cc8872","volume":"14","author":"C Pierrakos","year":"2010","unstructured":"Pierrakos, C. & Vincent, J.-L. Sepsis biomarkers: a review. Crit Care 14, R15 (2010).","journal-title":"Crit Care"},{"key":"BFsrep42179_CR9","first-page":"135","volume":"15","author":"K Lungstras-Bufler","year":"2004","unstructured":"Lungstras-Bufler, K. et al. High cytokine levels at admission are associated with fatal outcome in patients with necrotizing fasciitis. Eur. Cytokine Netw. 15, 135\u2013138 (2004).","journal-title":"Eur. Cytokine Netw."},{"key":"BFsrep42179_CR10","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ajem.2005.02.028","volume":"24","author":"RM Rodriguez","year":"2006","unstructured":"Rodriguez, R. M. et al. A pilot study of cytokine levels and white blood cell counts in the diagnosis of necrotizing fasciitis. Am J Emerg Med 24, 58\u201361 (2006).","journal-title":"Am J Emerg Med"},{"key":"BFsrep42179_CR11","doi-asserted-by":"publisher","first-page":"e119","DOI":"10.1002\/bjs.9371","volume":"101","author":"T Goh","year":"2014","unstructured":"Goh, T., Goh, L. G., Ang, C. H. & Wong, C. H. Early diagnosis of necrotizing fasciitis. Br J Surg 101, e119\u2013125 (2014).","journal-title":"Br J Surg"},{"key":"BFsrep42179_CR12","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1097\/01.CCM.0000129486.35458.7D","volume":"32","author":"C-H Wong","year":"2004","unstructured":"Wong, C.-H., Khin, L.-W., Heng, K.-S., Tan, K.-C. & Low, C.-O. The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score: a tool for distinguishing necrotizing fasciitis from other soft tissue infections. Crit. Care Med. 32, 1535\u20131541 (2004).","journal-title":"Crit. Care Med."},{"key":"BFsrep42179_CR13","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1111\/j.1445-2197.2008.04713.x","volume":"78","author":"Y-C Su","year":"2008","unstructured":"Su, Y.-C. et al. Laboratory risk indicator for necrotizing fasciitis score and the outcomes. ANZ J Surg 78, 968\u2013972 (2008).","journal-title":"ANZ J Surg"},{"key":"BFsrep42179_CR14","doi-asserted-by":"crossref","unstructured":"Kincius, M., Telksnys, T., Trumbeckas, D., Jievaltas, M. & Milonas, D. Evaluation of LRINEC Scale Feasibility for Predicting Outcomes of Fournier Gangrene. Surg Infect (Larchmt), doi: 10.1089\/sur.2015.076 (2016).","DOI":"10.1089\/sur.2015.076"},{"key":"BFsrep42179_CR15","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.1002\/lary.23680","volume":"122","author":"AJ Thomas","year":"2012","unstructured":"Thomas, A. J. & Meyer, T. K. Retrospective evaluation of laboratory-based diagnostic tools for cervical necrotizing fasciitis. Laryngoscope 122, 2683\u20132687 (2012).","journal-title":"Laryngoscope"},{"key":"BFsrep42179_CR16","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1007\/s11999-010-1311-y","volume":"468","author":"Y-H Tsai","year":"2010","unstructured":"Tsai, Y.-H., Hsu, R. W.-W., Huang, K.-C. & Huang, T.-J. Laboratory indicators for early detection and surgical treatment of vibrio necrotizing fasciitis. Clin. Orthop. Relat. Res. 468, 2230\u20132237 (2010).","journal-title":"Clin. Orthop. Relat. Res"},{"key":"BFsrep42179_CR17","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1177\/0310057X0903700416","volume":"37","author":"MJ Holland","year":"2009","unstructured":"Holland, M. J. Application of the Laboratory Risk Indicator in Necrotising Fasciitis (LRINEC) score to patients in a tropical tertiary referral centre. Anaesth Intensive Care 37, 588\u2013592 (2009).","journal-title":"Anaesth Intensive Care"},{"key":"BFsrep42179_CR18","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1016\/j.joms.2015.05.035","volume":"73","author":"A Sandner","year":"2015","unstructured":"Sandner, A., Moritz, S., Unverzagt, S., Plontke, S. K. & Metz, D. Cervical Necrotizing Fasciitis\u2013The Value of the Laboratory Risk Indicator for Necrotizing Fasciitis Score as an Indicative Parameter. J. Oral Maxillofac. Surg. 73, 2319\u20132333 (2015).","journal-title":"J. Oral Maxillofac. Surg."},{"key":"BFsrep42179_CR19","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1164\/ajrccm.164.3.2009052","volume":"164","author":"S Harbarth","year":"2001","unstructured":"Harbarth, S. et al. Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am. J. Respir. Crit. Care Med. 164, 396\u2013402 (2001).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"BFsrep42179_CR20","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1186\/s13054-014-0507-z","volume":"18","author":"M Behnes","year":"2014","unstructured":"Behnes, M. et al. Diagnostic and prognostic utility of soluble CD 14 subtype (presepsin) for severe sepsis and septic shock during the first week of intensive care treatment. Crit Care 18, 507 (2014).","journal-title":"Crit Care"},{"key":"BFsrep42179_CR21","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1056\/NEJM199902113400607","volume":"340","author":"C Gabay","year":"1999","unstructured":"Gabay, C. & Kushner, I. Acute-phase proteins and other systemic responses to inflammation. N. Engl. J. Med. 340, 448\u2013454 (1999).","journal-title":"N. Engl. J. Med."},{"key":"BFsrep42179_CR22","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.ccc.2006.03.003","volume":"22","author":"K Reinhart","year":"2006","unstructured":"Reinhart, K., Meisner, M. & Brunkhorst, F. M. Markers for sepsis diagnosis: what is useful? Crit Care Clin 22, 503\u2013519 (2006).","journal-title":"Crit Care Clin"},{"key":"BFsrep42179_CR23","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1308\/003588414X14055925058553","volume":"97","author":"GE Glass","year":"2015","unstructured":"Glass, G. E., Sheil, F., Ruston, J. C. & Butler, P. E. M. Necrotising soft tissue infection in a UK metropolitan population. Ann R Coll Surg Engl 97, 46\u201351 (2015).","journal-title":"Ann R Coll Surg Engl"},{"key":"BFsrep42179_CR24","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1111\/j.1469-0691.2010.03253.x","volume":"17","author":"BR Kittang","year":"2011","unstructured":"Kittang, B. R. et al. Invasive group A, C and G streptococcal disease in western Norway: virulence gene profiles, clinical features and outcomes. Clin. Microbiol. Infect. 17, 358\u2013364 (2011).","journal-title":"Clin. Microbiol. Infect."},{"key":"BFsrep42179_CR25","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1136\/bmj.330.7495.830","volume":"330","author":"S Hasham","year":"2005","unstructured":"Hasham, S., Matteucci, P., Stanley, P. R. W. & Hart, N. B. Necrotising fasciitis. BMJ 330, 830\u2013833 (2005).","journal-title":"BMJ"},{"key":"BFsrep42179_CR26","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1097\/00000658-199611000-00011","volume":"224","author":"DC Elliott","year":"1996","unstructured":"Elliott, D. C., Kufera, J. A. & Myers, R. A. Necrotizing soft tissue infections. Risk factors for mortality and strategies for management. Ann. Surg. 224, 672\u2013683 (1996).","journal-title":"Ann. Surg"},{"key":"BFsrep42179_CR27","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.2106\/00004623-200308000-00005","volume":"85\u2013A","author":"C-H Wong","year":"2003","unstructured":"Wong, C.-H. et al. Necrotizing fasciitis: clinical presentation, microbiology, and determinants of mortality. J Bone Joint Surg Am 85\u2013A, 1454\u20131460 (2003).","journal-title":"J Bone Joint Surg Am"},{"key":"BFsrep42179_CR28","doi-asserted-by":"crossref","unstructured":"Alejandria, M. M., Lansang, M. A. D., Dans, L. F. & Mantaring, J. B. Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock. Cochrane Database Syst Rev CD001090, doi: 10.1002\/14651858.CD001090.pub2 (2013).","DOI":"10.1002\/14651858.CD001090.pub2"},{"key":"BFsrep42179_CR29","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1086\/515199","volume":"28","author":"R Kaul","year":"1999","unstructured":"Kaul, R. et al. Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome\u2013a comparative observational study. The Canadian Streptococcal Study Group. Clin. Infect. Dis. 28, 800\u2013807 (1999).","journal-title":"Clin. Infect. Dis."},{"key":"BFsrep42179_CR30","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1086\/376630","volume":"37","author":"J Darenberg","year":"2003","unstructured":"Darenberg, J. et al. Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial. Clin. Infect. Dis. 37, 333\u2013340 (2003).","journal-title":"Clin. Infect. Dis."},{"key":"BFsrep42179_CR31","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1093\/cid\/ciu449","volume":"59","author":"A Linn\u00e9r","year":"2014","unstructured":"Linn\u00e9r, A., Darenberg, J., Sj\u00f6lin, J., Henriques-Normark, B. & Norrby-Teglund, A. Clinical efficacy of polyspecific intravenous immunoglobulin therapy in patients with streptococcal toxic shock syndrome: a comparative observational study. Clin. Infect. Dis. 59, 851\u2013857 (2014).","journal-title":"Clin. Infect. Dis."},{"key":"BFsrep42179_CR32","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.amsu.2015.07.017","volume":"4","author":"C Koch","year":"2015","unstructured":"Koch, C. et al. Intravenous immunoglobulin in necrotizing fasciitis - A case report and review of recent literature. Ann Med Surg (Lond) 4, 260\u2013263 (2015).","journal-title":"Ann Med Surg (Lond)"},{"key":"BFsrep42179_CR33","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1080\/00365540410020866","volume":"37","author":"A Norrby-Teglund","year":"2005","unstructured":"Norrby-Teglund, A. et al. Successful management of severe group A streptococcal soft tissue infections using an aggressive medical regimen including intravenous polyspecific immunoglobulin together with a conservative surgical approach. Scand. J. Infect. Dis. 37, 166\u2013172 (2005).","journal-title":"Scand. J. Infect. Dis."},{"key":"BFsrep42179_CR34","doi-asserted-by":"publisher","first-page":"e1005732","DOI":"10.1371\/journal.ppat.1005732","volume":"12","author":"K Chella Krishnan","year":"2016","unstructured":"Chella Krishnan, K. et al. Genetic Architecture of Group A Streptococcal Necrotizing Soft Tissue Infections in the Mouse. PLoS Pathog. 12, e1005732 (2016).","journal-title":"PLoS Pathog."},{"key":"BFsrep42179_CR35","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13054-016-1210-z","volume":"20","author":"MB Hansen","year":"2016","unstructured":"Hansen, M. B. et al. Pentraxin-3 as a marker of disease severity and risk of death in patients with necrotizing soft tissue infections: a nationwide, prospective, observational study. Crit Care 20, 40 (2016).","journal-title":"Crit Care"},{"key":"BFsrep42179_CR36","doi-asserted-by":"crossref","unstructured":"Hansen, M. B. et al. The Lectin Complement Pathway in Patients with Necrotizing Soft Tissue Infection. J Innate Immun, doi: 10.1159\/000447327 (2016).","DOI":"10.1159\/000447327"},{"key":"BFsrep42179_CR37","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s11255-014-0897-5","volume":"47","author":"O Bozkurt","year":"2015","unstructured":"Bozkurt, O., Sen, V., Demir, O. & Esen, A. Evaluation of the utility of different scoring systems (FGSI, LRINEC and NLR) in the management of Fournier\u2019s gangrene. Int Urol Nephrol 47, 243\u2013248 (2015).","journal-title":"Int Urol Nephrol"},{"key":"BFsrep42179_CR38","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1001\/jama.1993.03510240069035","volume":"270","author":"JR Le Gall","year":"1993","unstructured":"Le Gall, J. R., Lemeshow, S. & Saulnier, F. A new Simplified Acute Physiology Score (SAPS II) based on a European\/North American multicenter study. JAMA 270, 2957\u20132963 (1993).","journal-title":"JAMA"},{"key":"BFsrep42179_CR39","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/BF01709751","volume":"22","author":"JL Vincent","year":"1996","unstructured":"Vincent, J. L. et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction\/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 22, 707\u2013710 (1996).","journal-title":"Intensive Care Med"},{"key":"BFsrep42179_CR40","doi-asserted-by":"publisher","first-page":"e006995","DOI":"10.1136\/bmjopen-2014-006995","volume":"5","author":"MB Hansen","year":"2015","unstructured":"Hansen, M. B., Simonsen, U., Garred, P. & Hyldegaard, O. Biomarkers of necrotising soft tissue infections: aspects of the innate immune response and effects of hyperbaric oxygenation-the protocol of the prospective cohort BIONEC study. BMJ Open 5, e006995 (2015).","journal-title":"BMJ Open"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep42179.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep42179","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep42179.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,24]],"date-time":"2022-12-24T01:29:48Z","timestamp":1671845388000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep42179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,8]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,3,13]]}},"alternative-id":["BFsrep42179"],"URL":"https:\/\/doi.org\/10.1038\/srep42179","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,8]]},"assertion":[{"value":"8 August 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.P. and M.B.M. are sub-investigators on an RCT that is partly funded by CSL Behring. The Dept. of Intensive Care, Rigshospitalet receives support for research from Fresenius Kabi and Ferring Pharmaceuticals. The remaining authors have no potential conflicts of interest to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"42179"}}